Juan Echevarría

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

Jean‐Michel Molina, Jaime Andrade‐Villanueva, Juan Echevarría et al. · The Lancet · 2008 · 482 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey

Márcio Nucci, Flávio Queiroz‐Telles, Tito Alvarado-Matute et al. · PLoS ONE · 2013 · 375 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +12

Active Surveillance of Candidemia in Children from Latin America

Marı́a Elena Santolaya, Tito Alvarado Matute, Flávio Queiroz‐Telles et al. · The Pediatric Infectious Disease Journal · 2013 · 79 citations · Full text

Medicine, Microbiology, Pediatrics +17

HIV Stigma as a Barrier to Retention in HIV Care at a General Hospital in Lima, Peru: A Case–Control Study

Carla V. Valenzuela, César Ugarte‐Gil, Jorge Paz et al. · AIDS and Behavior · 2014 · 72 citations

Public Health, Community Health, Infectious Disease Control +15

Mobile learning for HIV/AIDS healthcare worker training in resource-limited settings

María Zolfo, David Iglesias, Carlos Kiyan et al. · AIDS Research and Therapy · 2010 · 68 citations · Full text

Education, Educational Technology, Medical Education +14